Mallinckrodt Pharmaceuticals Generics has entered into a strategic alliance with Zydus Cadila's US subsidiary, Zydus Pharmaceuticals Inc. The agreement calls for Mallinckrodt Pharmaceuticals Generics to market and sell products under a shared Mallinckrodt-Zypharma label. The products will be developed and registered by Zydus Pharmaceuticals and will be manufactured by Zydus Cadila at its US FDA-approved manufacturing plant in Ahmedabad, India.

By melding Mallinckrodt's marketing and distribution networks with Zydus Cadila's product development and manufacturing success, Mallinckrodt expands its product portfolio and pipeline.